fig2

Figure 2. Management workflow of comorbidities in post-LT setting^{[17,70,91-95]}. BMI: Body mass index; GLP1-RAs: glucagon-like peptide-1 receptor agonists; LT: liver transplantation; eGFR: estimated glomerular filtration rate; SGLT2: sodium-glucose cotransporter-2; CCBs: calcium channel blockers; ACE-I: angiotensin converting enzyme-inhibitor; ARBs: angiotensin receptor blockers; mTOR: mammalian target of rapamycin; EtG: ethyl glucuronide; PEth: phosphatidylethanol; AUD: alcohol use disorder.